TuHURA Biosciences, Inc./NV (HURA) Form 8-K Material Events
TuHURA Biosciences, Inc./NV (HURA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HURA
CIK: 1498382
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerAdam Hunter
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-09 | 8-K | 0001193125-26-424228 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-21 | 8-K | 0001193125-26-401140 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-14 | 8-K | 0001193125-26-394473 | View SEC Doc Filr Page |
| 8-K/A | 2026-09-17 | 2026-09-10 | 8-K/A | 0001193125-26-393847 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-10 | 8-K | 0001193125-26-393206 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-02 | 8-K | 0001193125-26-383797 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-28 | — | SCHEDULE 13D/A Filing | 0000897069-26-001732 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-20 | 8-K | 0001193125-26-361272 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-18 | 8-K | 0001193125-26-357087 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-350451 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-350425 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-07 | 8-K | 0001193125-26-349540 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-28 | 8-K | 0001193125-26-324174 | View SEC Doc Filr Page |
| ARS | 2026-07-09 | 2025-12-31 | ARS | 0001193125-26-299693 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-09 | — | DEFA14A | 0001193125-26-299690 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-09 | 2026-08-18 | DEF 14A | 0001193125-26-299680 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-06-30 | 8-K | 0001193125-26-297668 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-26 | 2026-08-18 | PRE 14A | 0001193125-26-285733 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001193125-26-274225 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-26 | 8-K | 0001193125-26-248640 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | FORM 4 | 0000897069-26-001285 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-227245 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001193125-26-227204 | View SEC Doc Filr Page |
| 8-K/A | 2026-04-30 | 2026-04-02 | 8-K/A | 0001193125-26-197609 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001193125-26-197486 | View SEC Doc Filr Page |